2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula
NCT ID: NCT00993746
Last Updated: 2010-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
90 participants
INTERVENTIONAL
2009-10-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation
NCT06570096
Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block
NCT06389617
PECS II Versus ICBN Block Plus SCNB for AV Fistula Creation in CRF Patients
NCT04988776
Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block
NCT06381622
Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction
NCT01593566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bupivacaine plus lidocaine
Group 1: bupivacaine 20 ml plus lidocaine 10 ml
Bupivacaine plus lidocaine
Bupivacaine 20 ml plus lidocaine 10 ml
Bupivacaine alone
Group 2: bupivacaine 30 ml
Bupivacaine 30 ml
Bupivacaine 30 ml for ultrasound guided infraclavicular brachial plexus block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine plus lidocaine
Bupivacaine 20 ml plus lidocaine 10 ml
Bupivacaine 30 ml
Bupivacaine 30 ml for ultrasound guided infraclavicular brachial plexus block
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>17 year
* BMI 20-35 kg/m2
* communicable
Exclusion Criteria
* History of allergy to local anesthetic drugs
* Pre-operative neurological deficit, Neuromuscular disorder หรือ old CVA
* Psychiatric disorder
* Coagulation disorder
* Uncontrolled seizure
* Pregnant and lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahidol University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orawan Pongrawewan, MD
Role: PRINCIPAL_INVESTIGATOR
Siriraj Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of anesthesiology Siriraj Hospital Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
si433/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.